Home
overview

For the latest COVID-19 Travel restrictions and recommendations please click here

SMi’s 10th Annual Conference
Pharmaceutical Microbiology UK
January 17 - 18, 2022 | London, UK
-------------------------------------------------------------------------
Microbiology remains an essential tool for the detection of microorganisms present in biopharmaceutical and pharmaceutical batches.
In recent years, the industry’s interest in microbiology has grown, this has been in part due to the growing resistance of certain bacteria to antibiotics, as well as the introduction of new technologies and automated solutions which provide more rapid results for faster clinical decisions -- making the most relevant information easily accessible to clinicians, significantly improving the operational efficiency of laboratories. Microbiological considerations continue to be one of the largest areas of investment from the pharmaceutical industry.

This conference will explore the most pressing topics in this thriving field, from the movement toward process automation and minimisation of operator intervention, to the latest technologies in rapid microbiological testing methods and data integrity.
 

To register your interest or to get involved please contact: eshambler@smi-online.co.uk
 

  • DISCOVER case studies in establishing holistic Contamination Control Strategies and Real-Time Viable Air Particle Counting with leaders in the pharmaceutical industry
  • GAIN insight the current state of Endotoxin testing, including alternative test methods and strategic approaches to method validation
  • EXPLORE the best practice in data integrity and the automation of environmental monitoring in the Microbiology Quality Control Lab
  • JOIN the important panel discussion on diversity and inclusion in the workplace with an experienced line-up of life science speakers
  • DISCUSS the latest developments in the detailed, rapid detection of microbes in pharmaceutical water
     

 

 

  • Heads of Aseptic Processing 
  • Heads of Microbiology
  • Global Quality Directors 
  • Heads of GMP Compliance
  • Quality & Compliance Heads
  • Microbiology Senior Specialists
  • Directors of Quality Control Biology
  • Quality Control Managers
  • Quality Assurance Managers
  • Lean Managers
  • Operations Managers
  • Heads of Site Compliance
  • Heads of Sterile Technology
  • Global Microbiology Analytical Experts
  • Cleanroom Managers
  • Regulatory Affairs Managers
  • Production Managers
  • Quality Systems Managers

Previous attendees include:
 

Allergy Therapeutics Ltd; AllergyTherapeutics; Associates of Cape Cod; Associates Of Cape Cod International; AstraZeneca; AstraZeneca PLC; Baxter; Baxter Healthcare Ltd; BioMerieux; bioMerieux UK Limited; BioPhorum; Boehringer Ingelheim; Boehringer Ingelheim Pharma GmbH & Co. KG; Charles River EMD; Christian Doppler Laboratory for Monitoring of Contaminants, University of Veterinary Medicine, Vienna; Copan; Copan Group; Copan Italia SpA; CTL - Mat; David P Elder Consultancy; European Patent Office; Fagron; Freeline; Fresenius Kabi; Fresenius Kabi UK Ltd; GSK; GSK Vaccines; GW Pharma ; King's College London ; Kite Pharma ; Lonza; MeiraGTx; Meriagtx; Mettler Toledo; Mettler Toledo Ltd; Mettler-Toledo Ltd; Mettler-Toledo Thornton; MHRA; MIcrobiologics; Microgenetics Ltd; Novo Nordisk; Oxford Biomedica Ltd; Paul Ehrlich Institut; PHSS: Pharmaceutical & Healthcare Sciences Society; Reading Scientific Services Ltd; Reading Scientific Services Ltd (RSSL); Regeneron Pharmaceuticals Inc.; RSSL; Sanofi-Aventis Deutschland GmbH; SDA Pharma; Steris Corporation; Techniconsult Firenze SRL; University of Veterinary Medicine Vienna; VCCN/Brookhuis Applied Data Intelligence; Veltek Associates, Inc.;
 

Conference programme

8:30 Registration & Coffee

9:00 Chair's Opening Remarks

Di Morris

Di Morris, Clinical Auditor, AstraZeneca
View Bio

9:10 Real-Time Viable Air Particle Counting: Technology and Validation

Peter Annel

Peter Annel, Principal Scientist, Novo Nordisk A/S
View Bio

• The principles of real-time counts of total and viable particles in pharmaceutical manufacturing environments:
        o Minimising aseptic interventions, streamlining investigations, and improving knowledge of the process
• Showcasing the monitoring technology and equipment
• Methodology behind the validation approach
 

9:50 Validation of a real-time PCR-based Rodent Parvovirus Detection Assay

Sven Deutschmann

Sven Deutschmann, Head of Global ASAT, Global QC, Roche Diagnostics GmbH
View Bio

• Background of Rodent Parvovirus Testing
• Development of a Rodent Parvovirus real time-PCR Assay
• Method Validation
 

10:30 Morning Coffee

11:00 How a next generation approach to data can help you maintain control

Andrew Davies

Andrew Davies, Microgenetics Managing Director, Microgenetics Ltd
View Bio

• What is Pharma 4.0 and key benefits
• Issues in digitalising the pharmaceutical industry: from regulation to “we’ve always done it this way” attitudes
• Benefits of digitalisation
• Digitalisation of environmental monitoring data and how this allows you to get more out of it
 

11:40 Panel Discussion: Diversity in Science: the importance of workplace diversity in life sciences

• Career negotiation tactics and best practice
• Significant challenges, biggest wins and failures
• Remote inspections
• Regulatory and clinical perspectives
• Identifying the barriers towards inclusion and diversity
• Advantages of diversity, equity, and inclusion over a homogenous workforce
 

Jim Polarine

Jim Polarine, Senior Technical Service Manager, Head of Microbiology & Sterile Technology, STERIS Corporation
View Bio

Suzanne Nutter

Suzanne Nutter, QA Group Manager, AstraZeneca

Di Morris

Di Morris, Clinical Auditor, AstraZeneca
View Bio

Pratixa Patel

Pratixa Patel, Senior Director, Microbiological and Stability Sciences, GSK
View Bio

12:20 Networking Lunch

13:20 The 5 year countdown to replace RPT and why the Ph. Eur. recommends MAT

Shabnam Solati

Shabnam Solati, CEO, CTL-MAT, LLC
View Bio

  • Overviewing the products that eventually require transition from RPT
  • Comparing the different in-vitro assays available and MAT’s unique suitability for all
  • Outlining critical patient safety risk often arising when RPT replaced with only BET;
  • Detailing MAT application as NEP risk assessment for BET or replacement of RPT as stand-alone batch release assay;
  • Surveying the key factors to look for when choosing a suitable MAT kit
  • 14:00 A Risk Assessment Approach to Address Fungal Spore Contamination in a Cell and Gene Therapy Cleanroom

    Jim Polarine

    Jim Polarine, Senior Technical Service Manager, Head of Microbiology & Sterile Technology, STERIS Corporation
    View Bio

    • Risk Assessment approach to fungal spore contamination in ATMP facilities
    • Walking the audience through key contamination risks in the ATMP cleanroom
    • Present efficacy data on disinfectants and sporicides to eliminate fungal spores in ATMP cleanroom operations
    • Highlighting the latest Annex I and FDA regulations and guidance documents related to contamination control in ATMP operations
     

    14:40 Afternoon Tea

    15:10 Sanofi Pasteur Mycoplasma techno roadmap and implementation of mycoplasma alternative method to release human vaccines

    Thierry Bonnevay

    Thierry Bonnevay, Microbiological Analytical Expert, Sanofi Pasteur
    View Bio

    • Regulatory background and Mycoplasma testing
    • Development of NAT methods
    • Validation of NAT method for Mycoplasma testing
    • Roadmap and Implementation for new vaccines and commercialized product
     

    15:50 Contamination Control Strategy - a wholistic way to maintain sterility assurance

    Martin Mullner

    Martin Mullner, Senior Quality Assurance Manager, Boehringer Ingelheim Pharma GmbH & Co. KG
    View Bio

    • Current status of EU GMP Annex-1-
    • Elements of a CCS and contaminants in scope
    • CCS hierarchy, structure, and lifecycle
    • Case Studies
     

    16:30 Applying QRM as part of a Contamination Control Strategy and EU GMP Annex 1

    Conor Murray

    Conor Murray, Principal Consultant, 3dimension Cleanrooms Limited

    • QRM and Contamination Control Strategy expectations in EU GMP Annex 1
    • GMP Compliance and Principles of establishing control and then demonstrating control
    • QRM and fundamental elements of a Contamination Control Strategy
    • Role of ISO/EN Standards and Classification VS Monitoring
    • Engineering Controls and the importance of Commissioning and Qualification as part of Annex 15 (Q&V)
    • Application of ISO 14644-2 and the new EN 17141 on microbiological control to integrated Non-Viable and Viable EM
    • Intelligent CCS decision making based on integrated EM data to ongoing GMP compliance
     

    17:10 Chair’s Closing Remarks and Close of Day One

    Di Morris

    Di Morris, Clinical Auditor, AstraZeneca
    View Bio

    8:30 Registration & Coffee

    9:00 Chair's Opening Remarks

    Di Morris

    Di Morris, Clinical Auditor, AstraZeneca
    View Bio

    9:10 The necessity of Data Integrity to the Microbial Quality Control Lab

    Di Morris

    Di Morris, Clinical Auditor, AstraZeneca
    View Bio

    • Harnessing accurate, relevant, and reliable data to automate processes and reduce risk
    • Automating endotoxin testing to remove as much potential for human error as possible
    • Removing subjectivity from testing through the use of objective and reagent-based automated software
    • Error-free microbial identification to support comprehensive environmental monitoring programmes
     

    9:50 From Visual Counting to Automation of Environmental Monitoring with the Growth Direct™

    Johannes Oberdoerfer

    Johannes Oberdoerfer, Scientist of Rapid Microbiology Methods, Boehringer Ingelheim Pharma GmbH & Co. KG
    View Bio

    • Build your business case to show the impact of automation in your lab
    • Define your validation strategy
    • The Growth Direct™ in routine
     

    10:30 Morning Coffee

    11:00 Developing Wipe Efficacy Validation for the Pharmaceutical Industry

    David Collins

    David Collins, Global Technical Consultant, Ecolab Life Sciences
    View Bio

    • Disinfectant efficacy for end user validation is demonstrated through performance testing to show that a disinfectant is capable of reducing microbial bioburden on cleanroom surfaces to an acceptable level
    • Of the different efficacy studies performed for disinfectant validation, surface studies with mechanical action (wiping) are regarded as the most challenging but most representative of actual cleanroom conditions and disinfectant application
    • Use of a harmonized wipe method can give companies a transferable platform to achieve replicable results between laboratories and between countries
    • Consideration of the factors discussed, including development of validation study controls, investigation of wipe material, wipe saturation and disinfectant application, will aid in the creation of a disinfectant efficacy study that will stand up to regulatory scrutiny across the globe
     

    11:40 Applying virtual reality to training in aseptic processing and microbiology

    • Overview of the technology
    • Rollout plan and approach
    • Pros and Cons of the technology for training
     

    Karen Capper

    Karen Capper, UK Site Microbiologist, AstraZeneca
    View Bio

    Suzanne Nutter

    Suzanne Nutter, QA Group Manager, AstraZeneca

    12:20 Networking Lunch

    13:20 Current state of Pyrogen- and Endotoxin Testing

    Ingo Spreitzer

    Ingo Spreitzer, Deputy Head, Section 1/3 Microbiological Safety, Paul Ehrlich Institut
    View Bio

    • Testing for Pyrogens and/or for Endotoxins?
    • Monocyte Activation Test
    • Recombinant Factor C and recombinant full cascade Endotoxin test
    • Regulation and Resistance
     

    14:00 Annex 1 and Environmental Monitoring Program - implementation and justification of the best practices in routine

    Benoit Ramond

    Benoit Ramond, Head of Microbiology & Sterile Technology, Sanofi
    View Bio

    • Annex 1 - Viable and Non-viable Environmental Monitoring Program
    • What is new? How to implement the changes?
    • EM program and Contamination Control Strategy
    • Example of Risk Analysis Methodology
    • EM program and Data Management
     

    14:40 Afternoon Tea

    15:10 Evolution of Microbiology testing

    Pratixa Patel

    Pratixa Patel, Senior Director, Microbiological and Stability Sciences, GSK
    View Bio

    • Approaching to bring speed to historically slower test methods
    • How to develop methods which are ‘fit for purpose’
    • Risk management program: how it adds confidence to rapid testing
     

    15:50 Alternative endotoxin test methods for products exhibiting low endotoxin recovery

    Ren-Yo Forng

    Ren-Yo Forng, Scientific Director, Amgen
    View Bio

    • The development of a suitable method to replace current endotoxin testing methods for products
    • A strategic approach to the evaluation and validation of testing methods
    • The future for finding a suitable replacement method – scope and reality check
     

    16:30 Chair’s Closing Remarks and Close of Day Two

    Di Morris

    Di Morris, Clinical Auditor, AstraZeneca
    View Bio

    +

    FEATURED SPEAKERS

    Andrew Davies

    Andrew Davies

    Microgenetics Managing Director, Microgenetics Ltd
    Benoit Ramond

    Benoit Ramond

    Head of Microbiology & Sterile Technology, Sanofi
    David Collins

    David Collins

    Global Technical Consultant, Ecolab Life Sciences
    Di Morris

    Di Morris

    Clinical Auditor, AstraZeneca
    Ingo Spreitzer

    Ingo Spreitzer

    Deputy Head, Section 1/3 Microbiological Safety, Paul Ehrlich Institut
    Jim Polarine

    Jim Polarine

    Senior Technical Service Manager, Head of Microbiology & Sterile Technology, STERIS Corporation
    Johannes Oberdoerfer

    Johannes Oberdoerfer

    Scientist of Rapid Microbiology Methods, Boehringer Ingelheim Pharma GmbH & Co. KG
    Karen Capper

    Karen Capper

    UK Site Microbiologist, AstraZeneca
    Martin Mullner

    Martin Mullner

    Senior Quality Assurance Manager, Boehringer Ingelheim Pharma GmbH & Co. KG
    Peter Annel

    Peter Annel

    Principal Scientist, Novo Nordisk A/S
    Pratixa Patel

    Pratixa Patel

    Senior Director, Microbiological and Stability Sciences, GSK
    Ren-Yo Forng

    Ren-Yo Forng

    Scientific Director, Amgen
    Shabnam Solati

    Shabnam Solati

    CEO, CTL-MAT, LLC
    Sven Deutschmann

    Sven Deutschmann

    Head of Global ASAT, Global QC, Roche Diagnostics GmbH
    Thierry Bonnevay

    Thierry Bonnevay

    Microbiological Analytical Expert, Sanofi Pasteur

    Andrew Davies

    Microgenetics Managing Director, Microgenetics Ltd
    Andrew Davies

    Andrew first joined Microgenetics as Head of Operations, his background in electronic and information engineering coupled with a keen interest in Microbiology making him a perfect fit for the team. During this time, he was responsible for the product development of SmartControl - our environmental monitoring software that helps users meet regulation, enhance data integrity and take better decisions. He worked across our team including microbiology research, machine learning and software development. A year later he became Managing Director, which takes us to today, where he leads the Microgenetics team in their Mission to help win the war against pathogens.

    Benoit Ramond

    Head of Microbiology & Sterile Technology, Sanofi
    Benoit Ramond

    Benoît Ramond is Doctor in Pharmacy at the University of Paris XI in France and obtains a PhD in Microbiology.
    He has more than 30 years of experiences in the Pharmaceutical Industry.
    Since 2016 he is Head of Microbiology and Sterile Technology Expertise in Sanofi Group. In his function he has also a leading role in the Annex 1 implementation program within Sanofi.
     

    Conor Murray

    Principal Consultant, 3dimension Cleanrooms Limited
    Conor Murray

    David Collins

    Global Technical Consultant, Ecolab Life Sciences
    David Collins

    David Collins is a graduate biologist holding over 8 years experience within pharmaceutical and cosmetic microbiology. Attending the University of Portsmouth, David obtained his First-Class honours in Biology later completing a placement within the stem cell research laboratories at the University of Palermo, Sicily. David began his career in microbiology within the cosmetics industry. He progressed as QA Microbiologist from a third-party cosmetics manufacturer joining The Estée Lauder group for the research and development of personal care products. Alongside the management of preservative efficacy testing and routine microbiological methods, he was responsible for reviewing and assessing deviations and conducting site audits globally to assess quality and validity of product manufacture and batch release testing. David has also held the position as microbiologist at GlaxoSmithKline, responsible for environmental quality assurance within the pharmaceutical manufacturing site. He performed microbiological monitoring for oral, sterile, primary and stability products adhering to strict GMP requirements and regularly analysing microbiological trends within the cleanroom and controlled environments. Prior to joining Ecolab, David was Quality Manager for a contract microbiology laboratory managing and maintaining the UKAS accredited Quality Management System ensuring compliance to ISO 17025 and to the GMP standards required by both MHRA and FDA.

    Di Morris

    Clinical Auditor, AstraZeneca
    Di Morris

    Di Morris - MRSC Chemistry and PGDiPS and a Qualified Person under permanent provisions since 1993; Pharmaceutical industry for over 30 years/ a number of years as a Medicines Inspector for the MHRA. Di/worked in the areas of Quality Control (Chemistry and Microbiology), Quality Assurance and Regulatory Affairs/worked with a wide range of dosage forms including sterile products, biological, and non-sterile products.
     

    Ingo Spreitzer

    Deputy Head, Section 1/3 Microbiological Safety, Paul Ehrlich Institut
    Ingo Spreitzer

    My former research topics (Lectins) and immune-activating components of bacteria introduced me to preparation /purification and bioassays, which until today influences my work on immune-activating / pyrogenic substances. I started at the PEI 2001 with the development and validation of the Monocyte activation test (MAT).
    My current duties as deputy at the PEI are drug QC by LAL (all methods) and Pyrogen testing (former rabbit pyrogen test, now replaced by MAT) and scientifically the exploration of the MAT. Our actual interests are drugs with intrinsic pyrogenicity, Outer membrane vesicles, synergistic effects and low Endotoxin recovery (LER).
     

    Jim Polarine

    Senior Technical Service Manager, Head of Microbiology & Sterile Technology, STERIS Corporation
    Jim Polarine

    Mr. Polarine is a senior technical service manager at STERIS Corporation. He has been with STERIS Corporation for twenty years. His current technical focus is microbial control in cleanrooms and other critical environments. Mr. Polarine is a 2019 PDA Michael S. Korczynski Award recipient. He has lectured in North America, Europe, Middle East, Asia, and Latin America on issues related to cleaning and disinfection, microbial control in cleanrooms and validation of disinfectants. Mr. Polarine is a frequent industry speaker and published several PDA book chapters and articles related to cleaning and disinfection and contamination control. He is active on the PDA’s COVID-19 Task Force and the PDA’s Microbial Excursions Task Force. He was a co-author on PDA’s Technical Report #70 on Cleaning and Disinfection. Mr. Polarine teaches industry regulators with FDA, MHRA, HPRA, ANVISA, and ANMAT as well as the pharmaceutical, biotech, and medical device industries at the PDA and the University of Tennessee. Mr. Polarine currently teaches the cleaning and disinfection course as part of the PDA Aseptic Processing Course and at the University of Tennessee Parenteral Medications Course. Mr. Polarine is current President for the PDA Missouri Valley Chapter and Technical Coordinator for the IEST. Mr. Polarine graduated from the University of Illinois with a Master of Arts in Biology. He previously worked as a clinical research coordinator with the Department of Veterans Affairs in St. Louis, MO and as a biology and microbiology instructor at the University of Illinois. His main hobby is storm chasing and is very active in tornado research and tornado safety.

     

    Johannes Oberdoerfer

    Scientist of Rapid Microbiology Methods, Boehringer Ingelheim Pharma GmbH & Co. KG
    Johannes Oberdoerfer

    The pharmaceutical company Boehringer Ingelheim was founded in 1885 by Albert Boehringer in Ingelheim am Rhein. From its beginnings in 1885 the company has since become a global enterprise with more than 50 000 employees.
    Boehringer Ingelheim BioXcellence™ is a world-leading biopharmaceutical contract manufacturer with tailor-made contract development and manufacturing services to the biopharmaceutical industry, providing the entire production technology chain from DNA to fill and finish under one roof.
    The Endotoxin testing lab has the challenge of managing and testing a large number of water samples on a daily basis, making it necessary for microbiology lab analysts to perform water endotoxin/LAL testing. The Endosafe® Nexus™ robotic endotoxin/LAL testing system combines a proven cartridge-based LAL technology (the multi-cartridge system, or MCS™) with a robotic system that carries and dilutes samples all the way through to completion. The Endosafe® Nexus™ system increases the laboratory throughput and efficiency while reducing potential pipetting variability and data entry errors with its sample bar code reader and ability to communicate with Labware LIMS.
     

    Karen Capper

    UK Site Microbiologist, AstraZeneca
    Karen Capper

    Karen is a pharmaceutical microbiologist with over 30 years’ experience in microbiology positions within the pharmaceutical industry. She has extensive knowledge in managing and operating QC microbiological and analytical laboratories as well as manufacturing experience in aseptic production. She has specialist knowledge in the microbiological assurance of aseptic processes, environmental control of non-sterile pharmaceuticals and API facilities. She currently leads the Global Microbiology Team in Product Development and is responsible for the microbiological assurance and testing of the products in development by AstraZeneca. Karen is also a course tutor for the PMAT Course at Manchester University where she tutors the GMP in Microbiology Laboratories and Antimicrobials Units.

    Martin Mullner

    Senior Quality Assurance Manager, Boehringer Ingelheim Pharma GmbH & Co. KG
    Martin Mullner

    06/2018 – dato Senior Quality Manager (Boehringer Ingelheim Corporate Center GmBH)
    • Global Quality Assurance for Aseptic Manufacturing / Environmental Monitoring & Microbial Testing. Steering of the global expert network, facilitating best practice sharing and production site support. Creating and maintaining the respective corporate document landscape. Member of global project teams for software solutions as process owner.
    12/2012 – 06/2018 Head of Quality Control Microbiology (Boehringer Ingelheim GmbH&Co.KG)
    • Local Management System Owner for Microbiology.
    • Environmental/Clean Utilities Monitoring Program for an aseptic filling line at the Ingelheim site.
    • Assessment and readout of aseptic processes (Media-Fill).
    • Microbial purity and sterility testing of API, excipient und drug product.
    • Comprehensive experience in inspections (e.g. FDA, ANVISA, KFDA, LSJV, etc.).
    • Project experience in the microbiological laboratory Redesign project, the RAMP-UP project of an aseptic filling line and as a Team Member of the ClassD Project at the Ingelheim site.
    • Member of the Aseptic Working Group.
    • Maintaining of an external network for the exchange of experience with active participation in benchmarking. This included organization of the annual meeting of the “VFA UA Mikrobiologie” 2017 and the annual meeting of the “CPM - Curriculum für Pharmazeutische Mikrobiologie” in 2013.
     

    Peter Annel

    Principal Scientist, Novo Nordisk A/S
    Peter Annel

    DVM in 1983. worked with microbiology since 1984. With Novo Nordisk since 1996, principal scientist since 2004. Worked in micro-QC, API production and product development, providing support and troubleshooting to micro-labs and API and FP production departments on microbial issues as well as training in general microbiology, aseptic behaviour etc.
    Member of EDQM group 1, Microbiology, since 2011.
     

    Pratixa Patel

    Senior Director, Microbiological and Stability Sciences, GSK
    Pratixa Patel

    I am working as a Senior Director (Head of Analytical, Microbiology and Stability) at GlaxoSmithKline Consumer Health, with 19 years of experience working in various roles in Microbiology, Analytical and Quality Assurance. I have previously worked at P&G and Dr Reddys Laboratories. I hold a BSc degree in Microbiology and Virology (University of Warwick, UK) and a PhD in Biofilm research from the University of Birmingham, UK.

    I started by career working in the laboratory before deciding to pursue a PhD, which I had undertaken as a young mother. It gave me a very important experience of time management, prioritisation and perseverance. I At Dr Reddys I held a position of Head of Microbiology for sterile, non-sterile and API manufacturing operations. I was responsible for setting the strategy to develop Microbiology systems and controls throughout the global supply chain and provided leadership to the micro function. Prior to that, I have worked at Procter & Gamble for 12 years including EMEA Regional Microbiology Head and Global head for Quality Analytical. I have held various assignments across R&D, Manufacturing and Commercial functions. My expertise is deeply rooted in Microbiology QbD, testing design, manufacturing controls, risk mitigation plans as well as organisational development of technical functions.
     

    Ren-Yo Forng

    Scientific Director, Amgen
    Ren-Yo Forng

    Ren-Yo Forng joined Amgen in 2015 as the Scientific Director of Microbiology in Process Development organization. His working experiences included research in microbiology and virology as well as manufacturing technical support and quality organizations in Bristol-Myers Squibb and AstraZeneca Biologics. Ren-Yo holds M.S. and Ph.D. degrees from the Laboratory of Microbial and Biochemical Sciences program from Georgia State University. He leads the effort in evaluation of innovative microbiological technologies, development and improvement of methods, and developing microbial control strategies in his role. Additionally, he supports subjects associated with manufacturing of drug substances and drug products where microbiology expertise or guidance is needed.

    Shabnam Solati

    CEO, CTL-MAT, LLC
    Shabnam Solati

    With 15 years experience in both academics and the field, Shabnam Solati is a key thought leader in the area of Monocyte Activation Testing (MAT). Having designed, produced and
    brought to market the world’s leading commercialised MAT kit, Shabnam partners with the very largest pharmaceutical manufacturers in their transition away from in-vivo assays towards the MAT as their batch release pyrogen test.

    Sven Deutschmann

    Head of Global ASAT, Global QC, Roche Diagnostics GmbH
    Sven Deutschmann

    Sven Deutschmann studied biology at the University of Brunswick where he obtained his PhD in cell culture technology. His current position is Head of Global Analytical Science and Technology “Adventitious Agents Testing & Alternative Microbiological Methods” within Global QC.

    Besides his internal responsibilities Sven is member of the German Pharmacopeia Commission, and the Microbiology Committee of the German Pharmacopeia Commission as well as Germany’s representative in the Working Parties “Bacterial Endotoxins”, “Mycoplasmas” (whose chairman he is) and Expert Group 1 “Biological Methods and Statistical Analysis” (whose chairman he is) of the European Pharmacopeia Commissions in Strasbourg, France. In 2009 he was appointed as commissioner of the Central Commission for Biological Safety, a brains trust of the Federal Office of Consumer Protection and Food Safety. In addition, Sven is chairman of the Advisory Board of the ECA “Pharmaceutical Microbiology” Interest Group.
     

    Thierry Bonnevay

    Microbiological Analytical Expert, Sanofi Pasteur
    Thierry Bonnevay

    Thierry Bonnevay has more than 25 years of experience in the field of microbiological quality control, acquired within the Sanofi Pasteur company and has held various positions in this field both in industrial affairs and in R&D. His current position is Global Analytical Microbiology Expert. He is a member of the USP Expert Group on Modern Microbiological Methods (MMM) since 2015 and a member of the European Pharmacopoeia Expert Group EDQM within Group 1 Microbiology (since 2016), the Bacterial Endotoxins Working Group (WP BET) since 2017 and the Mycoplasma Working Group (WP MYC) since 2018. Finally, he is part of the board of the French association A3P since 2017.

    Sponsors

    Official Media Partner

    Supporters

    Workshops

    VENUE

    Venue To Be Confirmed

    London, United Kingdom

    A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SMi Group. SMi Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
    HOTEL BOOKING FORM

    Pharmaceutical Microbiology 2022 Speaker Biographies

    Download

    Workshop A & B Detailed Programme

    Download

    Pharmaceutical Microbiology 2022 Agenda at a Glance

    Download

    Pharmaceutical Microbiology 2022 Detailed Programme

    Download

    Pharmaceutical Microbiology Conference 2022 Brochure

    Download

    Past Attendees List

    Download

    Past Speaker Presentation - AstraZeneca

    Download

    Past Speaker Presentation - PHSS

    Download

    Past Speaker Presentation - C.T.L. MAT

    Download

    Past Speaker Presentation - Fresenius Kabi

    Download

    Past Speaker Presentation - Copan

    Download

    Sponsors


    CTL-MAT

    Sponsors
    https://www.ctlmat.com/

    CTL-MAT - The MAT Company has been established to serve any and all of your Monocyte Activation Test needs, offering MAT Kits, Pooled PBMC, Batch Release Testing, Product-specific Validation and Consultation Services. The MAT is the only quantitative, in-vitro, true pyrogen test - measuring endotoxins and non-endotoxin pyrogens alike.


    Ecolab

    Sponsors
    https://en-uk.ecolab.com/

    Ecolab’s Life Sciences division is dedicated to developing the best possible products and services to support our customers in the pharmaceutical industry.

    Our comprehensive solutions and technical expertise are focused on cleaning, sanitisation and contamination control, all while ensuring safety, compliance and operational efficiency.



    Microgenetics

    Sponsors
    https://microgenetics.co.uk/

    Microgenetics is a biotech company specialising in microbiology, with two products currently:

    • SmartControl, allowing easy capture and analysis of microbiological environmental monitoring data and is pre-validated for GMP compliance

    • SwiftDetect, an ultra-sensitive rapid sterility test capable of detecting a single cell in a large sample volume in 6 hours


    Media Partners


    Rapid Microbiology.com

    Official Media Partner
    https://www.rapidmicrobiology.com

    rapidmicrobiology.com is a well-established on-line resource for microbiologists worldwide, find the right products for your microbiology lab using our specially designed search functions. To keep up-to-date with the latest microbiology news get our free weekly newsletter which includes updates on products, services, webinars, training courses and conferences.


    Biocompare

    Official Media Partner
    http://www.biocompare.com

    Biocompare.com is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.


    American Pharmaceutical Review

    Official Media Partner
    http://www.americanpharmaceuticalreview.com

    Start receiving your free copy today. American Pharmaceutical Review is a review of the drug pipeline from the late discovery phase through manufacturing. American Pharmaceutical Review prides itself on having the most relevant, unbiased and informative editorial in the industry. You will find that all of our editorial is highly technical and written by government agencies, consultants, academics, and large pharmaceuticals companies. American Pharmaceutical Review covers several key topics that are important to drug production:Separations and purification, Drug Delivery, Biopharmaceutical Processing, Biopharmaceutical Development, Formulation development, Manufacturing, Microbiology, Instrumentation, Spectroscopy

    Media Partners


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    Pharmaceutical Technology

    Supporters
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


    MedTube

    Supporters
    https://medtube.net/



    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today covers the whole of the preclinical drug discovery process. The reviews are cutting edge, written by experts in their respective fields and cover all aspects of drug discovery from genomic and proteomic approaches, computational drug design, medicinal chemistry and the translation of these sciences to therapies.


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    Drug Development Technology

    Supporters
    http://www.drugdevelopment-technology.com

    Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


    Contract Biotechnology

    Supporters
    http://www.contract-biotechnology.com

    Contract-Biotechnology.com is a web-based platform for laboratory outsourcing solutions. It is an online R&D matching tool that connects Scientifics and service and product providers worldwide. The platform Contract-Biotechnology.com would help you in the process of finding the right partner saving time and money, because with one single and secure application you would be able to receive multiple quotes quickly, keeping your contact information confidential. Contract-Biotechnology.com is the new Collaboration Network Model for Discovery Research and Development. Contract-Biotechnology.com team has extensive experience working for pharmaceuticals, biotechs, universities and academic research institutes and can help you addressing your key gaps.


    SciDoc Publishers

    Supporters
    http://www.scidoc.org

    SciDoc Publishers is a major source provider of e-journals in the field of Science, Technology and Medicine (STM). The nature of journals - Open Access and Peer-reviewed. We are aimed with a sole motive in making a mark in the field of Open Access, by propagating the knowledge to the scientific community. Our prime concern involves, the knowledge to reach millions of readers and give them access to scientific publications - online.


    Farmavita

    Supporters
    https://farmavitar.com

    FarmavitaR+ is the professional network of experts and service providers. Network is gathering local consultants from 90 countries in Europe, Asia, North America, Latin America, Australia and Africa. Management of international, multi-centre projects is our core competence. FarmavitaR+ is providing solutions related to pharmaceutical, medical device, food supplement and cosmetic products. Scope of services is related to solutions for product development, quality assurance, clinical trials, product registration, portfolio analysis, lifecycle management, vigilance/risk management, pricing/reimbursing, market access and promotional compliance. FarmavitaR+ is brand name of Farmavita Regulanet Ltd. Visit https://farmavitar.com for more information. Outsource anything you can think of!


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.


    Genetic Engineering News

    Supporters
    http://www.genengnews.com

    Genetic Engineering & Biotechnology News (GEN) is the most authoritative and widely read biotechnology news publication in the world.Published 21 times a year,GEN's unique news and technology focus include the entire bioproduct life cycle from early-stage R&D to applied research and bioprocess through to commercialization. GEN is the only publication that provides the full range of the biotechnology market coverage in areas such as omics, drugs and biomarker discovery, bioprocessing, clinical research, molecular diagnostics and biobusiness. For a free subscription go to: http://www.genengnews.com/subscriptions.aspx


    Pharmavision

    Supporters
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Venue To Be Confirmed

    London
    United Kingdom

    Venue To Be Confirmed

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SMi.
    Full details of our privacy policy can be found here https://www.smi-online.co.uk/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smi-online.co.uk.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out